Low-dose aspirin cuts colorectal cancer recurrence in patients with PI3K mutation, Nordic trial finds
Randomized study finds more than 50% reduction in three-year recurrence for colorectal cancer with PI3K pathway alterations; experts urge PI3K testing after surgery.